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Abstract: Prenatal vitamin D insufficiency may be associated with an increased risk of developing
childhood asthma. Results from epidemiological studies are conflicting and limited by short follow-up
and small sample sizes. The objective of this study was to examine if children born to women exposed
to the margarine fortification policy with a small dose of extra vitamin D during pregnancy had a
reduced risk of developing asthma until age 9 years, compared to children born to unexposed women.
The termination of a Danish mandatory vitamin D fortification policy constituted the basis for the
study design. We compared the risk of inpatient asthma diagnoses in all Danish children born two
years before (n = 106,347, exposed) and two years after (n = 115,900, unexposed) the termination of
the policy. The children were followed in the register from 0–9 years of age. Data were analyzed
using Cox proportional hazards regression. The Hazard Ratio for the first inpatient asthma admission
among exposed versus unexposed children was 0.96 (95%CI: 0.90–1.04). When stratifying by sex and
age, 0–3 years old boys exposed to vitamin D fortification showed a lower asthma risk compared to
unexposed boys (HR 0.78, 95%CI: 0.67–0.92). Prenatal exposure to margarine fortification policy with
extra vitamin D did not affect the overall risk of developing asthma among children aged 0–9 years but
seemed to reduce the risk among 0–3 years old boys. Taking aside study design limitations, this could
be explained by different sensitivity to vitamin D from different sex-related asthma phenotypes in
children with early onset, and sex differences in lung development or immune responses.
Keywords: asthma; fortification; vitamin D; social experiment
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1. Introduction
Asthma is one of the most common chronic conditions among children [1]. It is a complex
heterogeneous disease that affects both the respiratory and the immune system [2]. It manifests by
many phenotypes that vary by sex, age at onset, presence of obesity, as well as the severity of atopy,
allergic sensitization, bronchial obstruction, and hyperresponsiveness. Although genetic factors and
childhood exposure to environmental triggers, such as tobacco smoke, air pollution, viral infections or
aeroallergens play a major role in the development of childhood asthma [3], it has been suggested that
environmental exposures during gestation may also be important [4]. Asthma is more prevalent among
boys until puberty when a shift towards higher prevalence among girls and women is observed [5,6].
In children, this is thought to be due to sex differences in lung development and inflammatory
profile [7].
Vitamin D is a fat-soluble vitamin and a secosteroid hormone playing an important role in both
skeletal and non-skeletal functions [8]. It readily crosses the placenta and the fetal supply is totally
dependent on the supplies of the mother [9]. Results from animal and human studies have shown
that prenatal vitamin D insufficiency may influence both the intrauterine immune system [10] and
lung development [11,12], causing permanent changes to these systems. Such changes constitute
a plausible biological basis to suggest that vitamin D insufficiency during gestation may have a
programming effect contributing to the risk of childhood asthma. This is especially relevant given the
high prevalence of vitamin D insufficiency in pregnant women [13]. The research on the association
between prenatal vitamin D status and childhood asthma risk in the offspring is quite extensive. Results
from several systematic reviews and meta-analyses of observational studies, however, have been
inconsistent [14–18]. Two randomized clinical trials (RCT) have recently been conducted; both found
non-significant 20% reduced risk of asthma/recurrent wheeze among 0–3 year old children whose
mothers were supplemented with vitamin D during pregnancy [19,20], while a combined analysis of
the two trials showed a significant reduction in offspring’s asthma/recurrent wheeze risk after vitamin
D supplementation in pregnancy [21]. Despite sex differences in asthma prevalence and possible sex
difference in the effect of vitamin D on asthma development, few observational studies and none of the
RCTs have run analyses differentiated by sex. Furthermore, most of the previous studies had limited
numbers of participants and short follow-up periods [14–18,21].
In Denmark, between 1937 and 1985, it was mandatory to fortify margarine with 1.25 µg vitamin
D per 100 g [22]. The fortification accounted for on average 13% (3–29%) of total vitamin D intake
from food in the Danish population [22]. Despite that, the mandatory margarine fortification policy
was canceled in June 1985. This study utilized the design of this societal experiment grounded on the
distinct in time termination of the Danish margarine vitamin D fortification policy. The objective of the
present study was to examine if children born to women exposed to the margarine fortification policy
with a small dose of extra vitamin D during pregnancy had a reduced risk of developing asthma until
age 9 years compared to children whose mothers were unexposed to the fortification policy during
pregnancy. Furthermore, this study examined whether the association between exposure and asthma
risk varied by age, sex, and month of birth.
2. Methods
2.1. Study Design
This study is a part of the D-tect project and a detailed study design description has been published
elsewhere [23]. Briefly, all individuals born in Denmark during the two years before the termination of
the vitamin D policy in 1985 were considered as exposed to vitamin D fortification during prenatal life,
and all individuals born during the two years after the termination (excluding a wash-out period),
were considered unexposed to vitamin D fortification. The washout period consisted of 9 months for
the duration of a full-term pregnancy and an additional 6 months to allow for fortified products to be
commercially replaced by non-fortified products (Figure 1).
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All children born alive in Denmark from June 1983–May 1985 and from September 1986–August
1988 were identified using the Danish Civil Registration System (CRS) and included in this study. The
CRS was established in 1968 and includes information on all individuals alive and with permanent
residence in Denmark at that time, and those who were born in or immigrated to Denmark
afterwards [24]. All individuals in Denmark are assigned a unique identification number (CPR
number) that can be used to identify the individual in all national registers and databases. From the
CRS we retrieved information on the date of birth, date of death (if any), date of emigration or lost to
follow up (residence unknown to Danish authorities).
Individuals from our study population were followed in the Danish National Patient Register
(DNPR) to identify childhood asthma diagnoses. The DNPR is a national administrative register
established in 1977 that contains information on all hospital admissions, including discharge diagnoses,
according to the international classification of diseases (ICD) system [25]. Outpatient admissions in
DNPR were systematically registered from 1995, and to ensure comparable exposure groups with
complete follow-up among both exposed and unexposed individuals we only analyzed inpatient
asthma admissions in this study.
According to Danish law, ethical approval is not required for register-based studies. Permission
to access data was granted by Forskerservice, Statens Serum Institut (J.no. FSEID-00001369). The
Danish Data Protection Agency provided permission to process data (J.no. 2012-41-1156). The study is
registered at ClinicalTrials.gov (NCT03330301).
2.2. Definition of Outcome
Childhood asthma was defined as asthma diagnoses from birth to the age of 9 years. We considered
puberty as a cut-off for distinguishing childhood asthma from adult asthma, as puberty is the period
when there is a sex-based shift in the prevalence of asthma fro male predominance to female
predominance. In a previous study conducted among Danish children aged 6.0–19.9 years, the mean
age for the pre-pubertal stage was 10.88 (SD ± 8.66–13.11) years for girls and 11.83 (SD ± 9.92–13.75)
for boys [26], defining the age of 9 as a certain cut-off for pre-pubertal stage.
Asthma was defined based on ICD-8 codes 493.00, 493.01, 493.08 and 493.09; and from 1994
onwards on ICD-10 codes DJ45, DJ45.0, DJ45.1, DJ45.8, DJ45.9, DJ46.0, and DJ46.9. The registry
diagnoses of asthma have been previously validated against medical records [27].
2.3. Statistical Analysis
We conducted a time-to-event analysis focusing on the time of first inpatient asthma diagnosis.
If asthma was not diagnosed at the age of 9, or if the child became inactive in the CRS (emi rated,
lost o follow up or dead) before the age of 9, censoring took place. We used a Cox proportional
hazard model with age as the underlying time scale to assess the hazard ratios of first inpatient
asthma diagnosis in the group that was exposed to extra vit min D from fo tific ti n dur ng gestation
compared to the group that was unexposed to extra vitamin D from fortificat on. The assumption f
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proportional hazard was examined using Schoenfeld residuals [28]. Data were presented as the time at
risk, incident rate, and hazard ratio (95% confidence interval). Descriptive statistics were presented in
frequencies (N) and percentages (%). In multivariable analysis, we adjusted for sex and month of birth.
As we included entire birth cohorts of all individuals born in Denmark in adjacent years around the
fortification termination, other potential confounders were considered to be equally distributed in both
exposure groups, thus adjustment for other confounders was not deemed necessary.
To test our hypothesis that the greatest risk reduction would be observed among those who
had most of their prenatal period during the darkest months, we examined if the effect of vitamin D
fortification on asthma risk was modified by month of birth by the likelihood ratio test; the statistical
tests were two-sided at a 5% significance level. In addition, as decided a priory, we conducted analyses
stratified by sex and age at the time of asthma diagnosis hypothesizing potential effect modification by
sex and age, since the prevalence of asthma is higher among boys especially in the first few years of
life, and both sex and age are important characteristics of different asthma phenotypes [29].
All data management and descriptive statistics were performed using Stata 13 (StataCorp. 2013.
Stata Statistical Software: Release 13. College Station, TX, USA, www.stata.com), whereas all statistical
analyses were performed using R version 3.3.3 (R Foundation for Statistical Computing, Vienna,
Austria, www.R-project.org).
3. Results
Out of 222,247 children included in the study, 106,347 were born to mothers exposed to the
margarine fortification policy with extra vitamin D during pregnancy; 115,900 were born to unexposed
mothers. Among the exposed children, 1427 (64% boys) had inpatient asthma admission before the age
of 9 years; and among unexposed children, 1613 (65% boys) had inpatient asthma admission before the
age of 9 years (Figure 2 and Supplementary Table S1).
We did not observe a difference in inpatient asthma admission risk between children exposed and
unexposed to the margarine fortification policy with extra vitamin D during the prenatal period (HR
0.96, 95% CI: 0.90–1.03). Furthermore, there was no effect modification by month of birth (p = 0.28).
The Schoenfeld residuals indicated violation of the proportional hazards assumption with respect to
exposure status, and when stratified by age at first diagnoses, we found that among the 0–3 years
old, those exposed to extra vitamin D from fortification were less likely to have an inpatient asthma
admission (HR 0.86, 95% CI: 0.75–0.98) compared to unexposed ones. Further stratification by sex
revealed that reduced risk was confined to the 0–3-year-old boys. Boys of 0–3 years exposed to
the margarine fortification policy with extra vitamin D were less likely to have an inpatient asthma
admission (HR 0.78, 95% CI: 0.67–0.92) compared to unexposed ones. Adjusting for sex and month of
birth gave similar results (Table 1 and Figure 3).
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Table 1. Incidence, years at risk, rate, and hazard ratio (HR) of childhood asthma among those prenatally exposed to the margarine fortification with vitamin D policy,
compared to those unexposed.








HR (95% CI) Adjusted
†
HR
(95% CI) p for Interaction withMonth of Birth
Exposed Unexposed
All 1427 938,797 152.0 1613 1,022,110 157.8 0.96 (0.90–1.03) 0.96 (0.90–1.04) 0.28
0–3 years 393 315,879 124.4 498 343,928 144.8 0.86 (0.75–0.98) 0.86 (0.75–0.98) 0.63
4–6 years 596 312,640 190.6 682 340,339 200.4 0.95 (0.85–1.06) 0.95 (0.85–1.06) 0.02
7–9 years 438 310,278 141.2 433 337,843 128.2 1.10 (0.96–1.26) 1.10 (0.96–1.26) 0.78
Girls 515 457,866 112.5 562 496,107 113.3 0.99 (0.88–1.12) 0.99 (0.88–1.12) 0.30
0–3 years 146 153,849 94.9 153 166,624 91.8 1.03 (0.82–1.30) 1.03 (0.82–1.30) 0.98
4–6 years 221 152,494 144.9 248 165,223 150.1 0.97 (0.81–1.16) 0.97 (0.81–1.16) 0.14
7–9 years 148 151,523 97.7 161 164,259 98.0 1.00 (0.80–1.25) 1.00 (0.80–1.24) 0.41
Boys 912 480,931 189.6 1,051 526,003 199.8 0.95 (0.87–1.04) 0.95 (0.87–1.04) 0.50
0–3 years 247 177,304 194.6 345 162,030 152.4 0.78 (0.67–0.92) 0.78 (0.67–0.92) 0.24
4–6 years 375 175,116 247.8 434 160,146 234.2 0.94 (0.82–1.08) 0.95 (0.82–1.09) 0.10
7–9 years 290 173,583 156.7 272 158,755 182.7 1.17 (0.99–1.38) 1.16 (0.99–1.37) 0.71
† = adjusted for sex and month of birth, except girls and boys are only adjusted for month of birth.
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4. Discussion
Overall, we did not see a difference in the risk of asthma between children of both sexes age
0–9 years born to mothers exposed to the margarine fortification policy with a small extra dose of
vitamin D during their entire pregnancy compared to those who were born to mothers who were
unexposed. However, our analysis indicated that young children (0–3 years old), and in particular
boys born to exposed mothers, had more than 20% lower hazards for developing asthma compared to
boys born to unexposed mothers.
Several observational studies have examined the association between prenatal vitamin D and
the development of asthma in the offspring, however, the results have been mixed. There are several
potential reasons for this inconsistency. The observational studies have differed in study design,
number of participants, adjustment for covariates, the time at exposure assessment, the source material
for biomarker analysis, the concentration of maternal or cord blood 25(OH)D, and the assay method.
Early observational studies looking at vitamin D intake during pregnancy, usually assessed by food
frequency questionnaire (FFQ), and later development of asthma and wheezing, tended to find inverse
associations [30–32]. Vitamin D may have served as a marker of a healthier diet in general and
other dietary-related factors such as differences in the maternal microbiome [33]. The cohort studies
examining maternal or cord blood 25(OH)D tended to find no association between 25(OH)D level
in pregnancy and offspring asthma [34–36]. This was true across different timing of exposure and
outcome assessment as well as geographical settings. Total 25(OH)D level may not be a sufficient
indicator of the biologically available vitamin D, as other factors such as level of vitamin D binding
protein could influence the metabolism and bioavailability [37,38]. These studies also did not look at
the difference in asthma risk between different sex nor stratify according to pre-pregnancy vitamin D
status which may be more important for reducing asthma risk than vitamin D status in pregnancy. In
two recent randomized trials where mothers were supplemented with daily dose of 60 and 100 µg
vitamin D respectively during pregnancy [19–21], inverse associations between 25(OH)D level and
asthma/recurrent wheeze were strongest among women with a high 25(OH)D status at baseline
(≥75 nmol/L). This could indicate that the programming effect already takes place in early pregnancy
or even prior to pregnancy, and therefore, having optimal vitamin D status already at conception
might be important for reducing the risk of childhood asthma. This may be supported by the results
from observational studies assessing vitamin D intake as women with higher vitamin D intake during
pregnancy are likely to have had the same dietary pattern prior to pregnancy and thus have higher
vitamin D status at conception. In our study, the mothers were exposed to extra vitamin D from
fortification both during a long period prior to pregnancy and during the entire pregnancy. Thus, it
is expected that the exposed mothers had a higher vitamin D status pre-pregnancy than unexposed
mothers. It is important to stress that the vitamin D dose administered to the subjects in the two
trials was substantially higher than what women were exposed to from fortification in our study.
We have previously calculated, based on the fortification dose (1.25 µg/100g) and margarine intake
statistics, that an average additional 0.4–0.6 µg of vitamin D per day could be provided by the fortified
margarine [39]. Compared to vitamin D supplementation in the two trials (i.e. 60 and 100 µg), and in
light of the recommended total intake of 10 µg vitamin D per day for skeletal actions [40], the Danish
margarine fortification policy provided a very low extra vitamin D dose. However, the optimal vitamin
D dose for the prenatal development of the immune system and/or lung development is unknown.
Much higher supplementation doses provided in the two previously mentioned trials seemed to be
inadequate to reach a level of sufficiency among women during their pregnancy to prevent asthma
development in the offspring. In our study, a constant intake of a very low extra dose of vitamin D via
fortified foods consumption over entire pregnancy (and before pregnancy), might have been sufficient
to reduce the risk in the offspring with the highest risk of developing asthma, the youngest boys [7,41].
Methodological advantages and disadvantages of our societal experiment design study, if compared to
clinical trials, are discussed below under strengths and limitations.
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Asthma phenotypes are defined based on age at debut, the presence of atopy, allergic sanitization,
lung function, responsiveness to steroids, obesity, sex, and inflammatory profile. Many of these
different phenotypes vary according to age, making age an important parameter in identifying asthma
phenotypes [42]. Therefore, to try to isolate specific phenotypes, we stratified the analysis by age at
onset. Our results of a slight reduction in the risk of inpatient asthma admission among 0–3 years old
boys born to mothers who were exposed to the margarine fortification policy with extra vitamin D
during pregnancy are in accordance with the results from the combined analysis of the two recently
published RCTs showing a 26% reduction in the risk of asthma/recurrent wheeze at age 0–3 years
among those born to mothers who took vitamin D supplementation during pregnancy [21]. This
could indicate that vitamin D has an effect on asthma phenotypes that are prevalent in the youngest
children, especially boys, or that the programming effect is relatively weaker than the effect of the risk
factors accumulating during childhood. On the other hand, among children younger than 6 years,
and particularly those younger than 3 years, the asthma diagnosis is based on symptoms (wheezing,
cough, and breathlessness), clinical history of these symptoms, or family history of asthma or atopy,
whereas among older children and adults asthma is diagnosed based on symptoms and confirmed with
objective measures (spirometry, beta2 agonist reversibility test, bronchial provocation test, and peak
flow measurements) [3]. Wheezing is the most common clinical manifestation of asthma onset. As very
young children who experience severe and persistent wheezing are more likely to also have asthma
in childhood or adulthood [43,44], persistent wheezing in very young children usually is considered
to be an asthma indication. At the same time, many young children often experience wheezing due
to viral respiratory tract infections (RTI) without having or later developing asthma [44]. Notably, a
recent review on the association between maternal vitamin D status and RTI in offspring showed an
inverse association between exposure to vitamin D and RTIs (highest vs. lowest 25(OH)D level: OR
0.64, 95% CI: 0.47–0.87), but no association with asthma or wheezing [18]. Hence, it cannot be ruled out
that the protective effect observed among the 0–3-year-olds in our study was driven by a proportion of
children misdiagnosed with asthma because of wheezing due to viral RTI.
In regard to the sex differences, there are anatomic differences in lung size, maturity, and function
between the sexes with boys having larger lungs than girls, however, girls have higher forced expiratory
flow rates [7]. The lungs of newborn boys are also less mature than the lungs of newborn girls [45]
and thus are more vulnerable to respiratory infection, and consequently, asthma. Moreover, severe
allergic asthma, or asthma with multiple sensitizations to allergens, characterized by early onset,
high eosinophil count, and a low response to corticosteroid, is more prevalent among boys [29].
Children included in our study were children with asthma diagnosed during hospitalization, thus our
outcome measure captured the more severe cases of asthma. It is therefore possible that the protective
association observed among the youngest boys in our study was driven by the effects on an allergic
type of asthma. Interestingly, despite sex differences in the prevalence of asthma, and different asthma
phenotypes in boys and girls [44], very few studies have examined whether the effect of prenatal
vitamin D exposure on the development of asthma is sex-specific. We identified only one other study
that conducted sex-stratified analyses, and similarly to the results of the present study, the authors
found an inverse association between maternal vitamin D and asthma risk at 6 years among boys
only [46]. Consequently, vitamin D status in fetal life may contribute differently to the regulation of the
immunologic responses in boys and girls.
Based on the present study, we cannot conclude that exposure to the margarine fortification policy
with extra vitamin D during the prenatal period influences the risk of offspring asthma. However, our
results and those of prior studies may indicate that vitamin D intake, even in small amounts, early
in pregnancy or even before conception could influence the risk of asthma development, especially
among more vulnerable groups such as very young male children. Future studies of the association
between prenatal vitamin D and offspring asthma risk should assess vitamin D status or intervene
with vitamin D supplements periconceptually or prior to pregnancy. Furthermore, they should focus
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on different phenotypes of asthma, using biomarkers shown to have a good prognostic value, and
assessment of possible sex differences.
Strengths and Limitations
In this study we utilized a societal experiment of an abrupt abolishment of an obligatory vitamin D
fortification, that exposed all individuals living in Denmark to extra vitamin D from fortified margarine
during a distinct period of time when the fortification policy was implemented, and not thereafter. A
semi-ecological study design has both strengths and limitations.
The strength is that we could include all individuals born in Denmark from entire birth cohorts
from the Danish population, capturing all inpatient asthma admissions, which makes our results
generalizable for the entire Danish population. This was possible due to the excellent Danish
administrative and health registers, extensively used in Danish epidemiological research [47,48].
Additionally, asthma diagnoses in DNPR have been previously validated [27]. Another strength of
the design was that potential confounding (i.e., from differences in socioeconomic status, obesity,
maternal lifestyle and diet during pregnancy) can be considered to be equally distributed in both the
exposed and the unexposed groups as they included all individuals born in adjacent birth cohorts
around the time of the policy change. Nevertheless, secular trends in potential confounders during
this short period of time between 1983–1988 could have introduced residual confounding. Intake of
margarine was remarkably stable during the years around the policy change, and we were not able to
identify changes in national recommendations for intake and/or supplementation of vitamin D or in
fortification practice. However, a study from Denmark shows that smoking among women, a risk
factor for offspring asthma, decreased slightly during this period [49]. This would have attenuated
our findings and therefore speaks in favor of a true association between exposure to the margarine
fortification policy with extra vitamin D and the development of asthma. Furthermore, we know that
overweight and obesity, a risk factor for asthma, has been increasing among women [50], and from
1987–1988 there were changes in fiscal policy in Denmark that caused economic challenges for many
households [51,52]. It can be speculated that this economic crisis influenced overall diet quality, such
as decreased the intake of fish or fish oil, which is also shown to have a protective effect on asthma
development among offspring.
The limitation of this semi-ecological study design is that information on our exposure represents
ecological data; we do not have any information on actual vitamin D intake, neither from the fortified
margarine nor from other dietary sources and hence cannot make actual intake recommendations.
A further limitation of the study is that we only included in-patient discharge diagnoses and not
outpatients diagnoses and diagnoses by general practitioners, as the DNPR does not collect this
information. Consequently, we have a subgroup of asthmatic children, most likely those with severe
or uncontrolled asthma, and can generalize our results only to this group. Another study limitation
related to the nature of register data, which does not specify different phenotypes of asthma, nor
clinical parameters. To approximate this information, we conducted analyses stratified by age and
sex; however, even though the phenotypes differ by age and sex, there are other parameters that are
equally important, such as sensitization to allergens, responsiveness to steroids, and inflammatory
profile that would also be interesting to examine.
5. Conclusions
Our study, based on the societal experiment concerning margarine fortification with vitamin D
in Denmark, suggests that prenatal exposure to a small dose of extra vitamin D from fortification
may be associated with a lower risk of childhood asthma among boys aged 0–3 years, but not among
older children or the youngest girls. Asthma phenotypes with very early onset that have different
vitamin D sensitivity and/or sex differences in lung development or immune responses may explain
our findings. However, residual confounding effects due to the semi-ecological design of the study
cannot be ruled out.
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